What Stocks To Buy And Avoid? World Wrestling Entertainment, Inc. (WWE), OraSure Technologies, Inc. (OSUR) and Idera Pharmaceuticals Inc (IDRA)

Posted by admin May 19, 2015 0 Comment 1060 views

New York, NY – GDP INSIDER  –  05/19/2014.

This article discusses three companies: World Wrestling Entertainment, Inc. (NYSE:WWE), OraSure Technologies, Inc. (NASDAQ:OSUR) and Idera Pharmaceuticals Inc (NASDAQ:IDRA)

World Wrestling Entertainment, Inc. (NYSE:WWE) shares were up in trading yesterday by 1.8% to $13.91.  The entertainment company reported a new $35 million revolving credit facility with Bank of America Merrill Lynch.  The new facility will allow WWE to develop films and television projects.  It has not yet utilized the facility, but it could start to do so and make investments that will help grow revenues along with earnings.  The shares of WWE are down by 18% over the past 3-months and are below their moving averages.  We would look for the company to break through the moving average before a more sustainable move up.

Click Here To See Our Valuation For World Wrestling Entertainment, Inc In Our Free WWE Analysis.  

OraSure Technologies, Inc. (NASDAQ:OSUR) had a huge day in trading on Monday, increasing by $1.43 to $7.41.  The 24% increase in the stock came after big gains late last week.  The shares have increased by 40% over the past week.  The stock may be spiking as it does every May based on Hepatitis C awareness campaigns.  A newsletter also recommended the shares last week further contributing to its rise.  We are concerned the stock has come too far too fast and is due for a correction. We also question underlying fundamentals.

Click Here To See How Much Downside Rise We See In Our Free OSUR Investment Analysis.

Idera Pharmaceuticals Inc (NASDAQ:IDRA) was up by 12.4% in trading on Monday to close at $3.36.  The increase was on higher than average volume of 3.2 million shares versus the daily average of close to 2 million shares.   The company issued an update for its IMO-9200 product on Monday that caused the increase in the stock.  The treatment for inflammatory bowel disease successfully completed a phase 1 trial.  This is one step further in its development process and increases the likelihood the product will come to market.

Click Here To See The Updates Impact On The Valuation Of Idera Pharmaceuticals Inc In Free IDRA Report.

About Ultimate Stock Alerts

UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com

Disclosure:  UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment